LEG, FOOT & ANKLEDesign and descriptive data of the randomized Clubfoot Foot Abduction Brace Length of Treatment Study (FAB24)Dobbs, Matthew B.a,e; Frick, Steven L.f; Mosca, Vincent S.g; Raney, Ellenh; VanBosse, Harold J.i; Lerman, Joel A.j; Talwalkar, Vishwas R.k; Steger-May, Karend; Gurnett, Christina A.a,b,cAuthor Information aDepartments of Orthopaedic Surgery bNeurology cPediatrics dDivision of Biostatistics, Washington University eShriners Hospital for Children, St Louis, Missouri fNemours Children’s Hospital, Orlando, Florida gSeattle Children’s Hospital, Seattle, Washington hShriners Hospital for Children, Portland, Oregon iShriners Hospital for Children, Philadelphia, Pennsylvania jShriners Hospital for Children, Sacramento, California kShriners Hospital for Children, Lexington, Kentucky, USA Correspondence to Matthew B. Dobbs, MD, Department of Orthopaedic Surgery, Washington University in St Louis, St Louis, MO 63110, USA Tel: +1 314 454 4814; fax: +1 314 454 4817; e-mail: firstname.lastname@example.org Journal of Pediatric Orthopaedics B: March 2017 - Volume 26 - Issue 2 - p 101-107 doi: 10.1097/BPB.0000000000000387 Buy Metrics Abstract The aim of this study was to describe the design and baseline characteristics of participants enrolled in the prospective randomized-controlled Clubfoot Foot Abduction Brace Length of Treatment Study (FAB24). Foot abduction bracing is currently the standard of care for preventing clubfoot relapse. Current recommendations include full-time bracing for the first 3 months and then 8–12 h a day for 4 years; however, the optimal length of bracing is not known. The FAB24 trial is a clinical randomized study to determine the effectiveness of 2- versus 4-year foot abduction bracing. Participant enrollment for FAB24 was conducted at eight sites in North America and included enrollment and randomization of 139 participants with isolated clubfoot. This clinical trial will generate evidence-based data that will inform and improve patient care. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.